Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeline S Andrew

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
Human Genetics|March 3, 2009
Bladder cancer SNP panel predicts susceptibility and survivalAngeline S Andrew, Jiang Gui, Arthur C Sanderson, et al.
Human Heredity|September 28, 2007
DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategyAngeline S Andrew, Margaret R Karagas, Heather H Nelson, et al.
Cancer Biomarkers : Section a of Disease Markers|July 6, 2020
Identification of Let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancerKevin Shee, John D Seigne, Margaret R Karagas, et al.
Molecular Cancer Therapeutics|July 4, 2012
Evidence for the ubiquitin protease UBP43 as an antineoplastic targetYongli Guo, Fadzai Chinyengetere, Andrey V Dolinko, et al.
ISRN Pathology|April 1, 2014
Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004Alan R Schned, Petra Lenz, Lee E Moore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 2023
Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer OutcomesJi-Qing Chen, Lucas A Salas, John K Wiencke, et al.
Clinical Epigenetics|January 22, 2022
Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomesJi-Qing Chen, Lucas A Salas, John K Wiencke, et al.
Epigenomics|January 15, 2024
Matched analysis of detailed peripheral blood and tumor immune microenvironment profiles in bladder cancerJi-Qing Chen, Lucas A Salas, John K Wiencke, et al.
The Science of the Total Environment|September 26, 2018
Identifying aerosolized cyanobacteria in the human respiratory tract: A proposed mechanism for cyanotoxin-associated diseasesDominic N Facciponte, Matthew W Bough, Darius Seidler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Implications of LINE1 methylation for bladder cancer risk in womenCharlotte S Wilhelm, Karl T Kelsey, Rondi Butler, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Human Genetics|March 3, 2009
Bladder cancer SNP panel predicts susceptibility and survivalAngeline S Andrew, Jiang Gui, Arthur C Sanderson, et al.
Human Heredity|September 28, 2007
DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategyAngeline S Andrew, Margaret R Karagas, Heather H Nelson, et al.
Cancer Biomarkers : Section a of Disease Markers|July 6, 2020
Identification of Let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancerKevin Shee, John D Seigne, Margaret R Karagas, et al.
Molecular Cancer Therapeutics|July 4, 2012
Evidence for the ubiquitin protease UBP43 as an antineoplastic targetYongli Guo, Fadzai Chinyengetere, Andrey V Dolinko, et al.
ISRN Pathology|April 1, 2014
Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004Alan R Schned, Petra Lenz, Lee E Moore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 2023
Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer OutcomesJi-Qing Chen, Lucas A Salas, John K Wiencke, et al.
Clinical Epigenetics|January 22, 2022
Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomesJi-Qing Chen, Lucas A Salas, John K Wiencke, et al.
Epigenomics|January 15, 2024
Matched analysis of detailed peripheral blood and tumor immune microenvironment profiles in bladder cancerJi-Qing Chen, Lucas A Salas, John K Wiencke, et al.
The Science of the Total Environment|September 26, 2018
Identifying aerosolized cyanobacteria in the human respiratory tract: A proposed mechanism for cyanotoxin-associated diseasesDominic N Facciponte, Matthew W Bough, Darius Seidler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Implications of LINE1 methylation for bladder cancer risk in womenCharlotte S Wilhelm, Karl T Kelsey, Rondi Butler, et al.
Pageof 14